lonafarnib has been researched along with Lymphoma, B-Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bishop, JM; Charoenthongtrakul, S; Field, KA; Refaeli, Y | 1 |
1 other study(ies) available for lonafarnib and Lymphoma, B-Cell
| Article | Year |
|---|---|
Farnesyl transferase inhibitors induce extended remissions in transgenic mice with mature B cell lymphomas.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Farnesyltranstransferase; Flow Cytometry; Lymphocytes; Lymphoma, B-Cell; Methionine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Piperidines; Pyridines; Remission Induction | 2008 |